French Biotech Turns Fecal Bacteria Into a Cancer Drug

This video looks at how a French biotech firm is developing a cancer care drug based on bacteria from human feces, and why the microbiome has become a serious focus for pharma. It explains the science behind the approach, the promise it holds for treating disease, and the bigger industry shift now drawing interest from healthcare suppliers and drug developers alike. If you want a clear view of how microbiome research is moving from lab idea to clinical ambition, this is a concise look at one of the most unusual bets in modern medicine.